SynthesisFrontiers in pain research (Lausanne, Switzerland)2026
Efficacy and safety of different acupuncture-related therapies for primary trigeminal neuralgia: a systematic review and network meta-analysis.
Synthesis in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary trigeminal neuralgia (PTN) is a debilitating neuropathic pain disorder with limited long-term treatment options. Although acupuncture is widely used, the comparative effectiveness of different acupuncture modalities remains unclear. Objective: To compare the efficacy and safety of various acupuncture therapies for PTN using a network meta-analysis (NMA). Methods: Randomized controlled trials were identified through a systematic search of seven databases from database inception to 2 March 2026. Outcomes included total effective rate (TER), visual analogue scale (VAS), attack frequency (AF), traditional Chinese medicine syndrome score (TCMSS), and adverse events (AEs). A network meta-analysis was conducted, and treatments were ranked using SUCRA. Results: This network meta-analysis included 58 randomized controlled trials. The results showed that bloodletting therapy was identified as a potentially effective intervention for improving TER (RR = 2.00, 95% CI: 1.15-3.47; SUCRA = 95.6%; CINeMA: low certainty) and reducing VAS scores (MD = 0.07, 95% CI: 0.01-0.61; SUCRA = 87.4%; CINeMA: very low certainty). In contrast, acupuncture combined with conventional Western medicine performed better in reducing AF (MD = 0.05, 95% CI: 0.02-0.14; SUCRA = 100%; CINeMA: very low certainty), improving TCMSS (SMD = 0.15, 95% CI: 0.07-0.34; SUCRA = 90.7%; CINeMA: very low certainty), and decreasing the risk of AEs (OR=0.18, 95% CI: 0.12-0.28; SUCRA = 73.8%; CINeMA: moderate certainty). Conclusions: Different acupuncture modalities may offer distinct therapeutic benefits for PTN. Bloodletting therapy showed potential advantages in improving TER and reducing VAS, whereas acupuncture combined with conventional Western medicine appeared to perform better in reducing AF, improving TCMSS, and lowering the risk of AEs. However, these findings should be interpreted cautiously because of moderate-to-high heterogeneity across some outcomes and the generally low certainty of the evidence. Further large-scale, multicenter, high-quality randomized controlled trials are warranted to confirm these findings. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, PROSPERO (CRD420261339021).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.